Press Releases

Novasep Varicol high-performance continuous chromatography technology brings productivity gains in an Indian-based API commercial production Novasep, a leading supplier of manufacturing solutions to the life sciences industry, and its long-time partner Nilsan Nishotech Systems, a specialist...

Valbonne, France, November 7, 2014. – TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Damian...

TxCell (FR0010127662 - TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues(1) as of September 30, 2014. ...

CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in...

GTx Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's third quarter 2014 financial results on Monday November 10 at 9:00 a.m....

Neurocrine Biosciences to Present at the Nomura Biotechnology ConferenceLive Audio Webcast will be on November 6 2014 PR Newswire SAN DIEGO Nov. 3 2014 SAN DIEGO Nov. 3 2014 /PRNewswire/ -- Neurocrine Biosciences Inc. (Nasdaq: ...

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs,...